CTO Realty Growth, Inc. (CTO) Shares Decline Amid Wolfpack Report- Hagens Berman
CTO Investors with Losses Encouraged to Contact Hagens Berman
SAN FRANCISCO, June 26, 2025 /PRNewswire/ — On June 25, 2025 investors in CTO Realty Growth, Inc. (NYSE: CTO) saw the price of their shares significantly decline after Wolfpack Research published CTO: The B. Riley Of REITS, accusing CTO of misleading investors about its dividend sustainability and engaging in dubious financial activities.
This report has prompted national shareholders rights firm Hagens Berman to open an investigation into the allegations and whether CTO may have violated the securities laws. The firm urges CTO investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
Visit: www.hbsslaw.com/investor-fraud/cto
Contact the Firm Now:
CTO@hbsslaw.com
844-916-0895
CTO Realty Growth, Inc. (CTO) Investigation:
CTO represents itself as a 'self-managed equity REIT that focuses on the ownership, management, and repositioning of high-quality retail and mixed-use properties[.]'
The investigation is focused on the propriety of CTO's assurances to investors that it adheres to applicable accounting rules and its use of certain non-GAAP accounting metrics.
CTO's statements may have come into question on June 25, 2025, when Wolfpack published its report based, in part, on interviews with former employees and whistleblowers, in which it accuses CTO's management team of:
'[L]ying to investors about the sustainability of their dividend while enriching themselves[;]' and
'[E]ngag[ing] in accounting shenanigans like using a sham loan to cover up a top tenant's failure.'
In contrast to CTO's assurances of 'high-quality retail and mixed-use' exposures, Wolfpack identified a subset of CTO properties in extreme financial distress and concluded that CTO is focused on buying and managing aging shopping centers, has not generated sufficient cash to pay its recurring capex, and relies on dilution to cover a $38 million dividend shortfall.
The 'linchpin of management's deception,' according to Wolfpack, is its 'manipulative definition of Adjusted Funds From Operation (AFFO) where they exclude recurring capex, unlike all of their self-identified shopping center REIT peers[]' and management 'uses the same non-GAAP metric for 70% of its performance pay, inflating $8 million in bonuses we think they never should have received[.]'
'We're investigating whether CTO may have misled investors about the quality of its real estate portfolio, the reported asset values, and/or the propriety of its use of AFFO,' said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in CTO Realty Growth and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now »
If you'd like more information and answers to frequently asked questions about the CTO investigation, read more »
Whistleblowers: Persons with non-public information regarding CTO Realty Growth should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email CTO@hbsslaw.com.
About Hagens BermanHagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
6 hours ago
- New Straits Times
MONEY THOUGHTS: Of squeezes and substitutions
CAN you sense the snowballing righteous indignation of regular people at the arrogance and disrespect shown to them by political leaders — far and near? Globally, Donald Trump's tariffs on the whole world have angered entire continents, even as some cautious national leaders are taking a placatory stance toward him. Note: Even disregarding trade volumes for the moment, the sizable dip in the number of foreign students enrolling in American universities, and the cratering of tourist visits Stateside both bear testimony to one unsurprising truth: If you don't want me, I have options! While not true under monopolistic or monopsonistic circumstances, it is true most of the time. (In a monopoly, there is only one seller or provider of a good or service; so, a monopolistic vendor can raise prices to the roof. Conversely, in a monopsony, there is only one buyer, again, of a good or service; therefore, a monopsonistic buyer can — and almost always will — slam prices to the floor on a take-it-or-leave-it basis.) Thankfully, we — people and countries — have choices. So, while Trump considers the United States of America the economic centre of Earth, billions of people are waking up to the truth that 95.8 per cent of humanity lives outside America, and about 73 per cent of global GDP (gross domestic product) is generated within the other 192 member countries of the United Nations (and the two permanent observers, the Vatican and beleaguered Palestine). In most buy-and-sell transactions worldwide, the high-handed arrogance of entitled monopolists and monopsonists cannot gain traction because of one word: CHOICE. CHOICE AND SUBSTITUTION Fused onto the word "choice" like a semantic Siamese twin is the robust economic concept of "substitution", which applies to current American economic animosity toward most other countries, and also to the growing hordes of frustrated Malaysian consumers and business owners. People have choices when substitutions abound. You exercise this proactive power each time you dine out and scan menu items. If you see two meal options, which appeal equally to your growling stomach, you are likely to select the cheaper option. When extending the selection of options made from among several (or, better yet, many) economic choices, we humans usually revert to the common sense behaviour of rejecting those who reject us and instead seeking out those who are warm, friendly and accepting. For an extreme recent example, consider the sheer idiocy of the Trump administration barring eager, supersmart non-Americans from entering Harvard University. China's immediate (and massively logical) response was to welcome those brainiacs with open arms. Every country's future wealth is more dependent upon the scientific, technological and business acumen of a minority of talented people — regardless of where they were born — than upon the masses who believe mere birthright dubiously grants them some form of superiority. I suspect if America continues down this path of rejecting those who come from outside its shores, in less than a decade, other countries, led by wiser leaders, will grow at its expense. However, the proven self-correcting mechanisms in the American system of governance will probably permit the pendulum to swing back toward sanity in a few years. So, the advantage those of us who invest globally have is a vast range of choices for the allocation of our hard-earned, hard-won and hard-retained capital. Within our, ideally, globally diversified portfolios we should observe and think before acting. ECONOMIC RE-ENGINEERING Toward that end, the idea of substitution is readily understood, both within the SIPs (or savings and investment portfolios) we build lifelong wealth with, and within the narrow parameters of analysing the impact hiking a small country like Malaysia's sales and service (SST) rates can have. In case you missed it, there was an announcement that the Malaysian government will rake in an additional RM10 billion from its most recent hikes in certain SST rates. Time will tell if that durian runtuh -type harvest for government coffers materialises. You see, on the surface, having a competent, clean government that collects more tax revenue and which channels it toward enhancing the country's healthcare and education systems is laudable. However, that targeted extra RM10 billion flowing to the government is RM10 billion flowing OUT from the collective pockets of all Malaysians. It's been reiterated that 85 per cent of Malaysians won't be hurt too much, while the highest earning 15 per cent of Malaysian households shouldn't begrudge this economic re-engineering. Yet, in truth, dissatisfaction is rising like a king tide across all slices of the so-called privileged T15 — the 15 per cent of top-earning Malaysians. And the source of that dissatisfaction — increased taxes — will morph consumption habits across all socio-economic layers of this country. When we-the-people feel that disengaged authorities are squeezing us, we will respond rationally, logically, and decisively — to protect the economic well-being of those who matter most to us: our immediate families. Similarly, but on a larger scale, countries other than the US, especially across Asia, will evolve and grow new supply chains that exclude and sideline offensive rogue nations intent on rejecting or hurting them. Consider that as you contemplate your key investment choices over the next three-and-a-half years. © 2025 Rajen Devadason
Malaysian Reserve
14 hours ago
- Malaysian Reserve
ELV Deadline: ELV Investors with Losses in Excess of $100K Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit
NEW YORK, June 28, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the 'Class Period'), of the important July 11, 2025 lead plaintiff deadline. So what: If you purchased Elevance Health common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Elevance Health class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email case@ for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 11, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that, with the Medicaid redetermination process nearly complete, defendants represented to investors that they were closely monitoring cost trends associated with the redetermination process and that the premium rates Elevance was negotiating with states were sufficient to address the risk and cost profiles of those patients staying on Medicaid programs. While defendants acknowledged that Medicaid expenses were rising, they repeatedly assured investors that this was adequately reflected in Elevance's guidance for the year. These representations were materially false or misleading. In truth, the redeterminations were causing the acuity and utilization of Elevance's Medicaid members to rise significantly, as the members being removed from Medicaid programs were, on average, healthier than those who remained eligible for the programs. This shift was occurring to a degree that was not reflected in Elevance's rate negotiations with the states or in its financial guidance for 2024. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Elevance class action, go to or call Phillip Kim, Esq. at 866-767-3653 or email case@ for more information. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Kim, Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) 202-3827case@
BusinessToday
19 hours ago
- BusinessToday
PwC To Cut UK Audit Jobs, Scale Back Pay Raises
PricewaterhouseCoopers (PwC) is planning to lay off approximately 175 junior auditors in the UK and reduce salary increases across its workforce as the professional services sector grapples with a cooling market, Bloomberg reported quoting The Financial Times (FT) . According to the report, employees were informed they would receive a 2.5% salary hike starting in July, down from last year's 3%, as the firm responds to waning demand for some services and a notable drop in staff turnover. The unexpectedly low attrition has added pressure on firms to rebalance staffing levels. Sources told the FT that non-UK nationals on company-sponsored visas, who typically incur higher employment costs, were disproportionately affected by the cuts. The move signals heightened caution within the professional services industry, as firms adapt to a slowdown in client spending and broader economic headwinds. PwC has yet to issue a public statement on the reported changes. Related
